Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: A Children's Cancer Group report

Journal of Clinical Oncology

Volumn 20, Issue 9, 2002, Pages 2293-2301

  Lones, Mark A ^a   Perkins, Sherrie L ^a   Sposto, Richard ^a   Tedeschi, Nicole ^a   Kadin, Marshall E ^a   Kjeldsberg, Carl R ^a   Wilson, John F ^a   Zwick, David L ^a   Cairo, Mitchell S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HYDROXYUREA; IFOSFAMIDE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; HUMAN; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036570070     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.06.017     Document Type: Article

References (45)

1. Extranodal lymphomas of miscellaneous sites
2. Primary non-Hodgkin's lymphoma of bone: A clinicopathologic study
3. Primary non-Hodgkin's lymphoma of bone
4. Primary lymphoma of bone: A B-cell neoplasm with a high frequency of multilobated cells
5. Primary non-Hodgkin's lymphoma of bone: A clinicopathological investigation of 60 cases
6. Pediatric primary diffuse large cell lymphoma of bone with t(3;22)(q27;ql 1)
7. Anaplastic large cell Ki-I lymphoma of bone
8. Lymphoma presenting as a solitary bone lesion
9. Lymphoblastic lymphoma
10. Primary lymphoma of bone: The relationship of morphologic diversity to clinical behavior
11. Therapy for primary non-Hodgkin's lymphoma of bone and a comparison of results with Ewing's sarcoma: Ten years' experience at the Istituto Ortopedico Rizzoli
12. Malignant lymphoma of bone
13. Non-Hodgkin's lymphoma in bone: Pathologic and radiologic features with clinical correlates
14. The management of primary lymphoma of bone
15. Malignant lymphomas with primary bone manifestation
16. Primitive malignant lymphomas of bone: Study of 14 cases
17. Malignant lymphomas of bone in Japan
18. Localised lymphoma of bone: Prognostic factors and treatment recommendations
19. Treatment of stage IE primary lymphoma of bone
20. Localized primary malignant lymphoma of bone
21. Primary lymphoma of bone in children: Analysis of treatment results with Adriamycin, prednisone, Oncovin (APO), and local radiation therapy
22. Malignant lymphoma of bone in children
23. Bone involvement in young patients with non-Hodgkin's lymphoma: Efficacy of chemotherapy without local radiotherapy
24. Primary lymphoma of bone in children
25. Childhood malignant lymphoma of bone
26. Treatment of localized primary non-Hodgkin's lymphoma of bone in children: A Pediatric Oncology Group Study
27. Childhood nonHodgkin's lymphoma: The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)
28. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Childrens Cancer Group
29. The treatment of localized non-Hodgkin's lymphoma in children: A report from the Children's Cancer Study Group
30. Similar efficacy of 6 and 18 months of therapy with 4 drugs (COMP) for localized non-Hodgkin's lymphoma of children: A report from the Childrens Cancer Study Group
31. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: A Childrens Cancer Group Study
32. Daunomycin plus COMP vs COMP therapy in childhood non-lymphoblastic lymphomas
33. Disseminated nonlymphoblastic lymphoma of childhood: A Childrens Cancer Group Study. CCG-552
34. Disseminated non-lymphoblastic non-Hodgkin's lymphoma (DNLNHL) of childhood: A randomized phase II trial of short intensive treatment
35. Outcome of Children's Cancer Group (CCG) 5941: A pilot study for the treatment of newly diagnosed pediatric patients with disseminated lymphoblastic lymphoma
36. Treatment and outcome of pediatric large cell lymphoma (LCL) over 18 years (n=279): The Children's Cancer Group experience
37. Studies on the pathology of non-Hodgkin's lymphoma of childhood, I: The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group
38. Classification, staging, and end results of treatment of childhood non-Hodgkin's lymphomas: Disssimilarities from lymphomas in adults
39. Tumors of the hematopoietic system
40. Summary and description of a working formulation for clinical usage: The non-Hodgkin's lymphoma pathologic classification project
41. Non-Hodgkin's lymphoma in children
42. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
43. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
44. Classification of nonHodgkin's lymphomas in children